Diagnostic stewardship: Knowing when to submit and when to treat

The clinical microbiology laboratory is in the midst of a diagnostic revolution, marked by an ever-expanding testing menu. This is a direct result of the decentralisation of molecular (PCR) based testing during the COVID-19 pandemic, and the rapid expansion of point-of-care molecular tests. Amidst this expansion, it is crucial to reflect on the words of Dr John Bartlett from 1974, which still rings true today: “Our technical capabilities far exceed our ability to apply them effectively and economically to human problems”.

Management of cytomegalovirus reactivation in critically ill patients – significance and treatment implications

Cytomegalovirus (CMV) is a double-stranded DNA virus and a member of the Herpesviridae family. CMV seroprevalence is estimated to be 83% worldwide and generally increases with advancing age. It tends to be higher in developing countries, including South Africa (85%), than in developed countries.

Vaccines for senior adults: Safeguarding their health and well-being

Population ageing is a phenomenon which is being experienced in most countries across the globe. In South Africa, it is estimated that the population of senior adults or the elderly (i.e., aged ≥60 years) will almost double by the year 2050. The demographic transition is a concern as it will have implications on the health system if we do not adequately prepare for it. With the increasing proportions of senior adults, ensuring their health and wellbeing is of paramount importance.


Health Professions Council of South Africa


2 Clinical


Attempts allowed: 2

70% pass rate

Enquire Now

Infectious Diseases Updates - Vol 13 no 1 - 2024